BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 27465055)

  • 1. Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
    Di Tano G; Caretta G; De Maria R; Parolini M; Bassi L; Testa S; Pirelli S
    Heart; 2017 Jan; 103(1):71-77. PubMed ID: 27465055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive value of M30 and oxidative stress for left ventricular remodeling in patients with anterior ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Türkoğlu C; Gür M; Şeker T; Selek Ş; Koçyiğit A
    Coron Artery Dis; 2016 Dec; 27(8):690-695. PubMed ID: 27479531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low adiponectin blood concentration predicts left ventricular remodeling after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Piestrzeniewicz K; Luczak K; Maciejewski M; Drozdz J
    Cardiol J; 2010; 17(1):49-56. PubMed ID: 20104457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of NT-proBNP, 3D LA volume and LV dyssynchrony in patients with acute STEMI undergoing primary percutaneous intervention.
    Siva Sankara C; Rajasekhar D; Vanajakshamma V; Praveen Kumar BS; Vamsidhar A
    Indian Heart J; 2015; 67(4):318-27. PubMed ID: 26304563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of Speckle Tracking Echocardiography in Patients with ST-Elevation Myocardial Infarction Treated with Late Percutaneous Intervention.
    Cong T; Sun Y; Shang Z; Wang K; Su D; Zhong L; Zhang S; Yang Y
    Echocardiography; 2015 Sep; 32(9):1384-91. PubMed ID: 25471825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
    Ezekowitz JA; Armstrong PW; Granger CB; Theroux P; Stebbins A; Kim RJ; Patel MR
    Am Heart J; 2010 Aug; 160(2):272-8. PubMed ID: 20691832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum NT-proBNP on admission can predict ST-segment resolution in patients with acute myocardial infarction after primary percutaneous coronary intervention.
    Peng B; Xia H; Ni A; Wu G; Jiang X
    Herz; 2015 Sep; 40(6):898-905. PubMed ID: 25997425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure.
    Lok DJ; Lok SI; Bruggink-André de la Porte PW; Badings E; Lipsic E; van Wijngaarden J; de Boer RA; van Veldhuisen DJ; van der Meer P
    Clin Res Cardiol; 2013 Feb; 102(2):103-10. PubMed ID: 22886030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of microvascular resistance index immediately after primary percutaneous coronary intervention on left ventricular remodeling in patients with reperfused anterior acute ST-segment elevation myocardial infarction.
    Kitabata H; Kubo T; Ishibashi K; Komukai K; Tanimoto T; Ino Y; Kashiwagi M; Ozaki Y; Shiono Y; Shimamura K; Orii M; Hirata K; Tanaka A; Imanishi T; Akasaka T
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1046-54. PubMed ID: 24156965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neopterin predicts left ventricular remodeling in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P; Laynez-Cerdeña I; Kaski JC
    Atherosclerosis; 2010 Aug; 211(2):574-8. PubMed ID: 20451908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramyocardial dissecting hematoma in anterior wall ST elevation myocardial infarction: impact on left ventricular remodeling and prognosis.
    Spinelli L; Stabile E; Giugliano G; Morisco C; Giudice CA; Imbriaco M; Santoro M; Esposito G; Trimarco B
    Int J Cardiovasc Imaging; 2018 Feb; 34(2):201-210. PubMed ID: 28766162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive coronary flow reserve after successful primary angioplasty for acute anterior myocardial infarction is an independent predictor of left ventricular adverse remodelling.
    Meimoun P; Boulanger J; Luycx-Bore A; Zemir H; Elmkies F; Malaquin D; Doutrelan L; Tribouilloy C
    Eur J Echocardiogr; 2010 Sep; 11(8):711-8. PubMed ID: 20378685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of different serum biomarkers for left ventricular remodelling after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
    Urbano-Moral JA; Lopez-Haldon JE; Fernandez M; Mancha F; Sanchez A; Rodriguez-Puras MJ; Villa M; Lopez-Pardo F; Diaz de la Llera L; Valle JI; Martinez A
    Heart; 2012 Aug; 98(15):1153-9. PubMed ID: 22572051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Galectin-3 and outcomes after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
    Di Tano G; Caretta G; De Maria R; Bettari L; Parolini M; Testa S; Pirelli S
    Biomark Med; 2018 Jan; 12(1):21-26. PubMed ID: 29243525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Galectin-3 Levels Are Increased in Patients with Ischemic Heart Disease, but Are Not Influenced by Acute Myocardial Infarction.
    Singsaas EG; Manhenke CA; Dickstein K; Orn S
    Cardiology; 2016; 134(4):398-405. PubMed ID: 27120522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P
    Am J Cardiol; 2011 Oct; 108(7):955-8. PubMed ID: 21784389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Galectin-3 and left ventricular reverse remodelling after surgical mitral valve repair.
    Kortekaas KA; Hoogslag GE; de Boer RA; Dokter MM; Versteegh MI; Braun J; Marsan NA; Verwey HF; Delgado V; Schalij MJ; Klautz RJ
    Eur J Heart Fail; 2013 Sep; 15(9):1011-8. PubMed ID: 23576289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early discharge after primary percutaneous coronary intervention: the added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score.
    Schellings DA; Adiyaman A; Giannitsis E; Hamm C; Suryapranata H; Ten Berg JM; Hoorntje JC; Van't Hof AW
    J Am Heart Assoc; 2014 Nov; 3(6):e001089. PubMed ID: 25389283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NT pro-B-type natriuretic peptide levels are related to microvascular reperfusion in patients undergoing direct percutaneous transluminal coronary angioplasty for anterior ST-segment elevation myocardial infarction.
    Rossetti E; Mariani M; Poli A; Palmerini T; Finazzi S; Lotzniker M; Sangiorgi D; De Servi S
    J Cardiovasc Med (Hagerstown); 2010 May; 11(5):359-64. PubMed ID: 20051875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.